NPS Pharmaceuticals (NPSP) Says FDA Pushes Back PDUFA Date to Jan. 24
Tweet Send to a Friend
NPS Pharmaceuticals (NASDAQ: NPSP) reported that the FDA has extended the company’s Prescription Drug User Fee Act (PDUFA) action date ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE